These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6971701)

  • 1. Alkaline phosphatase positive lymphomas: a morphologic, immunologic, and enzymehistochemical study.
    Poppema S; Elema JD; Halie MR
    Cancer; 1981 Mar; 47(6):1303-12. PubMed ID: 6971701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas.
    Nanba K; Jaffe ES; Braylan RC; Soban EJ; Berard CW
    Am J Clin Pathol; 1977 Nov; 68(5):535-42. PubMed ID: 335871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a T-cell antigen (Leu-1) by B-cell lymphomas.
    Burns BF; Warnke RA; Doggett RS; Rouse RV
    Am J Pathol; 1983 Nov; 113(2):165-71. PubMed ID: 6605688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkaline phosphatase activity in non-Hodgkin's lymphomas and pseudolymphomas of the skin.
    Geerts ML; Burg G; Schmoeckel C; Braun-Falco O
    J Dermatol Surg Oncol; 1984 Apr; 10(4):306-12. PubMed ID: 6608543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histochemical and immunohistochemical study of diffuse large-cell lymphomas.
    Li CY; Harrison G
    Am J Clin Pathol; 1978 Nov; 70(5):721-32. PubMed ID: 82397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological markers in non-Hodgkin's lymphomas.
    Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme histochemistry of non-Hodgkin's lymphomas.
    Mikata A; Harigaya K; Suzuki H; Ohishi T; Tsutsumi Y; Suzuki S; Watanabe S; Kageyama K
    Acta Pathol Jpn; 1979 Sep; 29(5):739-53. PubMed ID: 158938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological classification of non-Hodgkin malignant lymphoma. II. Comparison between Rappaport's classification and the Kiel classification.
    Glimelius B; Hagberg H; Sundström C
    Scand J Haematol; 1983 Jan; 30(1):13-24. PubMed ID: 6836219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoblastic lymphoma/leukemia of T-cell origin: ultrastructural, cytochemical, and immunologic features of ten cases.
    Navas Palacios JJ; Valdes MD; Pallares MA; Gomez de Salazar MD; Garcia Marcilla A
    Cancer; 1981 Nov; 48(9):1982-91. PubMed ID: 6975156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictability of immunologic phenotype of malignant lymphomas by conventional morphology: a study of 60 cases.
    Frizzera G; Gajl-Peczalska KJ; Bloomfield CD; Kersey JH
    Cancer; 1979 Apr; 43(4):1216-24. PubMed ID: 376087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell-rich lymphoproliferative disorders. Morphologic and immunologic differential diagnoses.
    Winberg CD; Sheibani K; Burke JS; Wu A; Rappaport H
    Cancer; 1988 Oct; 62(8):1539-55. PubMed ID: 2901904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine malignant lymphomas: comparison of morphologic and immunologic parameters.
    Holmberg CA; Manning JS; Osburn BI
    J Natl Cancer Inst; 1976 Jan; 56(1):125-35. PubMed ID: 768497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle zone lymphoma. Immuno- and enzymehistochemical studies on the cell of origin.
    van den Oord JJ; de Wolf-Peeters C; Pulford KA; Mason DY; Desmet VJ
    Am J Surg Pathol; 1986 Nov; 10(11):780-8. PubMed ID: 2946246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkaline phosphatase positive lymphoma.
    Geerts ML; Burg G; Schmoeckel C; Braun-Falco O
    Dermatologica; 1984; 169(6):342-7. PubMed ID: 6335434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant lymphoma of true histiocytic (monocyte/macrophage) origin.
    Isaacson P; Wright DH; Jones DB
    Cancer; 1983 Jan; 51(1):80-91. PubMed ID: 6336974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.